Natural Matrix Composition for Standardized Cancer Microenvironment Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, particularly plant-based medicines, face challenges with lack of standardization, regulatory issues, and limited clinical evidence, hindering their widespread use despite showing promise in targeting cancer cells with lower toxicity and synergistic effects.
Innovation Solution
A product composed of natural matrices from Filipendula, Laurus, Brassica, Withania, Cynara, and Curcuma, which is standardized and demonstrates therapeutic functional resilience, enhancing the efficacy of anticancer drugs by modifying the whole pathological state rather than individual biological functions, and is validated through probabilistic models based on bio-physical interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If plant-based medicines are used for cancer treatment, then lower toxicity and synergistic effects are achieved, but lack of standardization and limited clinical evidence hinder widespread use
Solution Approach 1:
The patent applies parameter changes by standardizing the plant-based medicine through controlled extraction parameters, concentration levels, and formulation specifications. This transforms variable natural products into consistent therapeutic agents with defined potency and safety profiles, resolving the contradiction between maintaining natural benefits and achieving pharmaceutical standardization
Solution Approach 2:
The invention creates composite materials by combining multiple plant extracts with specific chemical compositions in defined ratios. This composite approach consolidates synergistic effects while establishing reproducible formulations that meet standardization requirements, enabling reliable clinical application
2Reliability
If natural matrices are processed through specific processes, then therapeutic effect is enhanced, but complexity of production process increases
Solution Approach 1:
The production process is segmented into distinct modular stages: extraction, filtration, concentration, formulation, and quality control. Each stage is independently optimized and validated, making the complex overall process more manageable, reproducible, and suitable for industrial manufacturing while preserving therapeutic efficacy
Solution Approach 2:
The patent replaces traditional mechanical processing methods with advanced techniques such as supercritical fluid extraction, ultrasonic assistance, and controlled precipitation. These substitutions improve extraction efficiency and product consistency while reducing physical complexity of equipment requirements
3Measurement precision
If conventional molecular chemical definitions are used for validation, then individual substances can be characterized, but overall effectiveness and quality cannot be validated
Solution Approach 1:
The patent employs a multi-functional validation approach that combines conventional molecular chemical analysis with spectroscopic methods (NIR, mass spectrometry, NMR) and fractal measurements. This universal validation system simultaneously characterizes individual substances and assesses overall product quality and effectiveness, resolving the limitation of single-method approaches
Data Source
Figure 1~3
Figure 4A~4C
Figure 5
AI summary
The present invention relates to a 100% natural product consisting of natural matrices showing emerging properties, which allows to re-establish a correct metabolism in tissues infiltrated by cancer cells, adjuvating cancer treatment and tissue homeostasis. The product of the invention, as demonstrated by the inventors, is itself a natural matrix, representing native natural intelligence, said natural intelligence being the only capable to allow a physiological endogenous interconnection with other entities which are self-assembled in nature, such as the human species. By modulating tumor microenvironment and thus selectively inducing cancer cells mortality, the product achieves reconstitution of conditions favourable to tissue homeostasis in tissues infiltrated by cancer cells. Factually, the invention allows for a shift of paradigm based on the passage from a deterministic validation of properties to a probabilistic one based on functional redundancy logics, that will grant an industrially viable source of innovation for manufacturers in the field of 100% natural therapeutic or beneficial products.